A Japanese pharmaceutical consortium announced the advancement of a new chemotherapy-based mesothelioma treatment option to Phase II clinical trials of patients suffering from pleural malignant mesothelioma.
The Agency for Toxic Substances and Disease Registry (ATSDR) has identified the groups of people most at risk for potential asbestos exposure from the Libby vermiculite mine.
For the residents of Libby, Montana, justice is finally at hand. After a three year long test of wills, a criminal trial date has been set for executives of WR Grace. Read the rest of this entry »
Comments rss
TrackbackIn spite of the clear link between asbestos exposure and mesothelioma, the United States government has so far shied away from an all-out ban of asbestos due to the material’s extensive utility. Asbestos is regulated, but industry pressure has prevented the complete ban of the substance. Read the rest of this entry »
Under peer review, the Environmental Protection Agency’s (EPA) experiment with a supposedly more cost-effective asbestos-containing material removal methods exposed several potentially dangerous flaws that could expose the public to asbestos. Read the rest of this entry »
One of the promises of asbestos abatement is the removal of the threat of mesothelioma and other asbestos-related diseases. Abatement procedures are carefully regulated so that the workers do not expose themselves or any one else to threat of melanoma with improper handling techniques. Read the rest of this entry »
The Asbestos Disease Awareness Organization (ADAO), a non-profit volunteer organization dedicated to the advancement of asbestos disease awareness, education, treatment and prevention, will be hosting the 5th Annual Asbestos Disease Awareness Day Conference in March of 2009.
Read the rest of this entry »
